By Jenna Greene | March 15, 2018
“If you don't like the law, change it” is a fine slogan—but what if doing so is a way to duck an otherwise valid Freedom of Information Act request and shut down the flow of information to the public?
By Scott Graham | March 14, 2018
In a blistering complaint, Blink Health and its lawyers at Gibson, Dunn & Crutcher accuse two former executives of misappropriating source code, marketing plans and even unused company slogans.
By Jenna Greene | March 13, 2018
Here's your daily reminder that our civil justice system depends on good-faith compliance with discovery requests. And that judges don't take it kindly if they suspect you're cheating. PLUS Buckley Sandler's $2.6B settlement
By Marcia Coyle | March 5, 2018
Lisa Blatt of Arnold & Porter, representing Endo pharma, argued New Hampshire was barred from outsourcing public claims "to private contingency-fee lawyers who have a substantial personal financial stake in the outcome." The Supreme Court turned down the petition without comment. New Hampshire's Cohen Milstein retainer agreement transferred to Motley Rice last year after the departure of Linda Singer.
By Sue Reisinger | February 28, 2018
It looks as though general counsel and legal departments may be a little more willing to litigate over blocked mergers than they have been in the past.
By Max Mitchell | February 27, 2018
Sessions outlined plans to create a new litigation-oriented task force within the Department of Justice to pursue claims against opioid manufacturers and distributors.
By Scott Graham | February 23, 2018
The decision ends—for now—a controversy that erupted last summer when Allergan paid the Saint Regis Mohawk Tribe to assume its Restasis patents in a creative legal strategy to fend off challengers.
By Tom McParland | February 22, 2018
In late 2016, Gilead Sciences Inc. and a Fish & Richardson trial team led by Jonathan Singer were hit with a $2.5 billion jury verdict, the largest ever recorded in a U.S. patent infringement case. Here's how they turned the tables on Merck.
Delaware Business Court Insider | News
By Tom McParland | February 20, 2018
A Delaware federal judge on Feb. 16 overturned a massive $2.5 billion jury verdict against Gilead Sciences Inc., finding that a patent held by a unit of Merck & Co. Inc. was too broad to be valid.
By Jenna Greene | February 11, 2018
"In order to do a good job at trial, you can't just parachute in and know half the facts. You have to know everything," says Kirkland & Ellis star litigator James Hurst. "The reality is, that takes time—late nights, early mornings, lots of weekends. But it's the only way to make it work."
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
Black Owl Recruiting is looking for a number of qualified applicants to fill positions for a highly reputable client. Recent experience work...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS